- Exchange: SIX Swiss Ex
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Actelion Ltd+ Add to Watchlist
ATLN:VX72.000 CHF 1.900 2.57%
As of 11:43:58 ET on 12/04/2013.
Company Profile for Actelion Ltd (ATLN)
Actelion Ltd. is a pharmaceutical company that develops and markets synthetic small-molecule drugs against diseases related to the endothelium. The Company's drugs, Veletri and Tracleer, are used in the treatment of heart and pulmonary conditions.
Key Executives for Actelion Ltd (ATLN)
|Jean-Paul ClozelCEO/Co-Founder||Andre C MullerChief Financial Officer|
|Otto SchwarzExec VP/COO||Guy BraunsteinExec VP/Head:Clinical Dev|
|Marian BorovskySenior VP/Secy/General Counsel||Martine ClozelSenior VP/Head:Drug/Co-Founder|
|Christian AlbrichSenior VP/Head:Human Resources||Roland HaefeliSenior VP/Head:Investor Relations|
|Nicholas FrancoVP/Chief Bus Dev Officer|